High-performance production no longer means more of the same, as in the past, but more variety and flexibility. However, increasing production requirements must not mean that the demand for product quality is lost. Sanochemia demonstrates precisely this highly competitive combination of flexible production and top product quality: agile innovation processes, investment in new production facilities and high quality standards make it possible.
There are only a few plants in Austria that manufacture both finished pharmaceutical products and active pharmaceutical ingredients. With the production of contrast agents, which are highly concentrated solutions, Sanochemia has focused on a technically challenging niche. In future, Sanochemia also intends to use the know-how acquired for this purpose for new products in the finished products segment. "Our train concept with a series of approach rooms allows flexible production at a very high production level," says CEO Dr. Timo Bender.
During production, all parts in contact with the product are used for only one product group. "This approach, combined with our in-depth know-how in the analytical field, allows us to offer a broad production range as well as high-quality output," adds plant manager Dr Beate Kälz.
Sanochemia also places great emphasis on the continuous improvement of product and process quality. "We have set ourselves the goal of meeting the high-quality requirements of the American FDA in 2021/2022," emphasises Dr. Timo Bender. "Important milestones for this are the introduction of an innovative paperless QMS system and, above all, a fundamental qualification and validation upgrade of all equipment, software components and facilities in our sterile production as well as in our analytical laboratory."